Perspective: The clinical trial barriers

作者: Liang Liu , Elaine Lai-Han Leung , Xiaoying Tian

DOI: 10.1038/480S100A

关键词: Gender studiesTianClinical trialPerspective (graphical)Sociology

摘要: To investigate traditional Asian medicines properly, we need to rethink the way they are tested, say Liang Liu, Elaine Lai-Han Leung and Xiaoying Tian.

参考文章(7)
Charles Swanton, Carlos Caldas, None, From genomic landscapes to personalized cancer management-is there a roadmap? Annals of the New York Academy of Sciences. ,vol. 1210, pp. 34- 44 ,(2010) , 10.1111/J.1749-6632.2010.05776.X
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Jan van der Greef, Herman van Wietmarschen, Jan Schroën, Mei Wang, Thomas Hankemeier, Guowang Xu, Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine Planta Medica. ,vol. 76, pp. 2036- 2047 ,(2010) , 10.1055/S-0030-1250450
Jean-Yves Douillard, Frances A. Shepherd, Vera Hirsh, Tony Mok, Mark A. Socinski, Radj Gervais, Mei-Lin Liao, Helge Bischoff, Martin Reck, Mark V. Sellers, Claire L. Watkins, Georgina Speake, Alison A. Armour, Edward S. Kim, Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial Journal of Clinical Oncology. ,vol. 28, pp. 744- 752 ,(2010) , 10.1200/JCO.2009.24.3030
J Guillermo Paez, Pasi A Janne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J Eck, William R Sellers, Bruce E Johnson, Matthew Meyerson, EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. ,vol. 304, pp. 1497- 1500 ,(2004) , 10.1126/SCIENCE.1099314
Herman van Wietmarschen, Kailong Yuan, Cheng Lu, Peng Gao, Jiangshan Wang, Cheng Xiao, Xiaoping Yan, Mei Wang, Jan Schroën, Aiping Lu, Guowang Xu, Jan van der Greef, Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. Jcr-journal of Clinical Rheumatology. ,vol. 15, pp. 330- 337 ,(2009) , 10.1097/RHU.0B013E3181BA3926